Supriya Lifescience
27 July, 2024 07:12
BSE:
543434
NSE:
SUPRIYA
ISIN:
INE07RO01027
Start SIP in Supriya Lifescience
Start SIPSupriya Lifescience Performance
Day Range
- Low 380
- High 392
52 Week Range
- Low 235
- High 425
- Open Price383
- Previous Close383
- Volume291981
Supriya Lifescience Financials
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 158 | 140 | 140 | 132 | 142 |
| Operating Expenses Qtr Cr | 103 | 99 | 108 | 88 | 87 |
| Operating Profit Qtr Cr | 56 | 41 | 32 | 44 | 55 |
| Depreciation Qtr Cr | 4 | 4 | 4 | 4 | 3 |
| Interest Qtr Cr | 1 | 0 | 0 | 1 | 1 |
| Tax Qtr Cr | 16 | 10 | 6 | 14 | 15 |
| Net Profit Qtr Cr | 37 | 30 | 24 | 29 | 38 |
Supriya Lifescience Technicals
EMA & SMA
Current Price
₹387.8
+
4.65
(1.21%)
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹392.06
- 50 Day
- ₹386.71
- 100 Day
- ₹371.99
- 200 Day
- ₹345.17
- 20 Day
- ₹397.63
- 50 Day
- ₹383.53
- 100 Day
- ₹375.23
- 200 Day
- ₹332.29
Supriya Lifescience Resistance and Support
PIVOT
₹386.47
| Resistance | |
|---|---|
| First Resistance | 392.88 |
| Second Resistance | 397.97 |
| Third Resistance | 404.38 |
| RSI | 47.80 |
| MFI | 54.17 |
| MACD Single Line | 2.16 |
| MACD | -0.84 |
| Support | |
|---|---|
| First Support | 381.38 |
| Second Support | 374.97 |
| Third Supoort | 369.88 |
Supriya Lifescience Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 306,249 | 18,926,188 | 61.8 |
| Week | 196,009 | 10,927,524 | 55.75 |
| 1 Month | 291,209 | 14,452,698 | 49.63 |
| 6 Month | 480,067 | 18,794,609 | 39.15 |
Supriya Lifescience Result Highlights
Supriya Lifescience Synopsis
NSE-Medical-Supplies
Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 460.94 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2023. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.| Market Cap | 3,121 |
| Sales | 570 |
| Shares in Float | 2.58 |
| No of funds | 44 |
| Yield | 0.21 |
| Book Value | 3.83 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | |
| Alpha | 0.07 |
| Beta | 0.98 |
Supriya Lifescience Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 68.3% | 68.3% | 68.3% | 68.3% |
| Mutual Funds | 0.13% | 0.05% | 0.04% | 1.74% |
| Insurance Companies | 3.82% | 3.71% | 3.81% | 3.89% |
| Foreign Portfolio Investors | 4.95% | 5.37% | 4.56% | 5.35% |
| Individual Investors | 17.19% | 17.06% | 17.51% | 16.1% |
| Others | 5.61% | 5.51% | 5.78% | 4.62% |
Supriya Lifescience Management
| Name | Designation |
|---|---|
| Mr. Satish Waman Wagh | Chairman & Managing Director |
| Ms. Smita Satish Wagh | Whole Time Director |
| Ms. Saloni Satish Wagh | Whole Time Director |
| Ms. Shivani Satish Wagh | Whole Time Director |
| Mr. Balasahab Gulabrao Sawant | Whole Time Director |
| Mr. Kedar Shankar Karmarkar | Independent Director |
| Mr. Bhairav Manojbhai Chokshi | Independent Director |
| Mr. Dileep Kumar Jain | Independent Director |
| Mr. Dinesh Navnitlal Modi | Independent Director |
| Ms. Neelam Yashpal Arora | Independent Director |
Supriya Lifescience Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Supriya Lifescience Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-28 | Audited Results & Final Dividend | |
| 2024-02-07 | Quarterly Results | |
| 2023-11-07 | Quarterly Results | |
| 2023-08-03 | Quarterly Results | |
| 2023-05-26 | Audited Results & Final Dividend |
Supriya Lifescience FAQs
What is Share Price of Supriya Lifescience ?
Supriya Lifescience share price is ₹387 As on 27 July, 2024 | 06:58
What is the Market Cap of Supriya Lifescience ?
The Market Cap of Supriya Lifescience is ₹3121.1 Cr As on 27 July, 2024 | 06:58
What is the P/E ratio of Supriya Lifescience ?
The P/E ratio of Supriya Lifescience is 26.2 As on 27 July, 2024 | 06:58
What is the PB ratio of Supriya Lifescience ?
The PB ratio of Supriya Lifescience is 3.8 As on 27 July, 2024 | 06:58